A controlled double blind study of azathioprine in the management of Crohn's disease.

Salomon P, Kornbluth A, Aisenberg J, Janowitz HD. How effective are current drugs for Crohn's disease. A metaanalysis. J Clin Gastroenterol 1992; 14: 211-5.

Best WR, Bectel JM, Singleton JW, Kern F. Development of a Crohn's Disease Activity Index. Gastroenterology 1976; 70: 439-44.

Yach D, McIntyre D, Saloojee Y. Smoking in South Africa: the health and economic impact. Tobacco Control 1992; 1: 272-80.

Willoughby JMT, Kumar PJ, Beckett J, Dawson AM. Controlled trial of azathioprine in Crohn's disease. Lancet 1971; ii: 944-7.

Rhodes J, Bainton D, Beck P, Campbell H. Controlled trial of azathioprine in Crohn's disease. Lancet 1971; ii: 1273-6.

Klein M, Binder HJ, Mitchell M, Aaronson R, Spiro H. Treatment of Crohn's disease with azathioprine: a controlled evaluation. Gastroenterology 1974; 66: 916-22.

Rosenberg JL, Levin B, Wall AJ, Kirsner JB. A controlled trial of azathioprine in Crohn's disease. Dig Dis 1975; 20: 721-6.

O'Donoghue DP, Dawson AM, Powell-Tuck, Bown RL, Lennard-Jones JE. Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease. Lancet 1978; ii: 955-7.

Summers RW, Switz DM, Sessions JT Jr, Becktel JM, Best WR, Kern F Jr, et al. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology 1979; 77: 847-69.

Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS. Treatment of Crohn's disease with 6-mercaptopurine. A long-term randomised double-blind study. NEnglJrMed 1980; 302: 981-7.

Ewe K, Press AG, Singe CC, Stufler M, Ueberschaer B, Hommel G, et al. Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease. Gastroenterology 1993; 105: 367-72.

Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn's disease: a meta-analysis. Gastroenterology 1994; 106: A1045.

O'Brien JJ, Bayless TM, Bayless JA. Use of azathioprine or 6 mercaptopurine in the treatment of Crohn's disease. Gastroenterology 1991; 101: 39-46.

Present DH, Meltzer SJ, Wolke A, Korelitz BI. Shortand long-term toxicity to 6-mercaptopurine in the treatment of inflammatory bowel disease. Ann Intern Med 1989; 3: 641-9.

Colonna T, Korelitz BI. The role of leukopenia in the 6mercaptopurine-induced remission of refractory Crohn's disease. AmJ Gastroenterol 1994; 89: 362-6.

Korelitz BI, Present DH. Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease. Dig Dis Sci 1985; 30: 58-64.

Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989; 34: 1841-54.